The Food and Drug Administration has given its blessing to Amphastar Pharmaceuticals for dextrose injection 50% in the 50-ml Luer-Jet Prefilled Syringe System. The medication is a sterile, ...
The Global Dextrose Injection Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a ...
Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...
The research report explores major market consultation of Global Buffered Intrathecal Electrolyte/Dextrose Injection Market after performing accomplished, intellectual and comprehensive analysis. The ...
The company is recalling the product because of out-of-specification results for high molecular weight polymers. Braun Medical Inc. (B. Braun) is voluntarily recalling one lot of 2g Ceftazidime for ...
3 Department of Family Medicine, University of Wisconsin, Madison, Wisconsin, USA 4 Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA Purpose To evaluate whether ...
Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results